Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (336)
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
14,351
Price
$108.83
Total Value
$1.56M
Shares Held After
3,318,839
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,197
Price
$128.69
Total Value
$282.73K
Shares Held After
2,862,688
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
159
Price
$108.02
Total Value
$17.18K
Shares Held After
3,333,190
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
25,075
Price
$127.37
Total Value
$3.19M
Shares Held After
2,864,885
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
9,994
Price
$107.30
Total Value
$1.07M
Shares Held After
3,333,349
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,609
Price
$126.71
Total Value
$203.88K
Shares Held After
2,889,960
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,716
Price
$125.82
Total Value
$467.55K
Shares Held After
2,891,569
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
11,711
Price
$124.61
Total Value
$1.46M
Shares Held After
2,895,285
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
10,860
Price
$123.62
Total Value
$1.34M
Shares Held After
2,906,996
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
4,977
Price
$122.67
Total Value
$610.53K
Shares Held After
2,917,856
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
40,774
Price
$121.38
Total Value
$4.95M
Shares Held After
2,922,833
% of Holdings
1.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
112,299
Price
$120.66
Total Value
$13.55M
Shares Held After
2,963,607
% of Holdings
3.7%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
37,179
Price
$119.71
Total Value
$4.45M
Shares Held After
3,075,906
% of Holdings
1.2%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
5,394
Price
$20.00
Total Value
$107.88K
Shares Held After
115,005
% of Holdings
4.5%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
28,935
Price
$20.06
Total Value
$580.51K
Shares Held After
13,579
% of Holdings
68.1%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
2,500
Price
$119.00
Total Value
$297.50K
Shares Held After
50,195
% of Holdings
4.7%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
2,500
Price
$109.00
Total Value
$272.50K
Shares Held After
52,695
% of Holdings
4.5%
ImmunityBio, Inc. (IBRX)
Simon Barry J. — Director
Shares
25,000
Price
$7.88
Total Value
$196.91K
Shares Held After
2,802,788
% of Holdings
0.9%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
100
Price
$27.77
Total Value
$2.78K
Shares Held After
26,804
% of Holdings
0.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
3,400
Price
$26.98
Total Value
$91.73K
Shares Held After
26,704
% of Holdings
12.7%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
3,000
Price
$25.98
Total Value
$77.94K
Shares Held After
23,304
% of Holdings
12.9%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
2,891
Price
$25.22
Total Value
$72.91K
Shares Held After
20,304
% of Holdings
14.2%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
14,565
Price
$78.41
Total Value
$1.14M
Shares Held After
245,571
% of Holdings
5.6%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President & Immunovant CEO
Shares
46,234
Price
$33.51
Total Value
$1.55M
Shares Held After
1,613,063
% of Holdings
2.8%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President & Immunovant CEO
Shares
153,766
Price
$33.05
Total Value
$5.08M
Shares Held After
1,659,297
% of Holdings
8.5%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
6,696
Price
$50.00
Total Value
$334.80K
Shares Held After
519,227
% of Holdings
1.3%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
837
Price
$315.70
Total Value
$264.25K
Shares Held After
2,337
% of Holdings
26.4%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
1,279
Price
$314.90
Total Value
$402.76K
Shares Held After
3,174
% of Holdings
28.7%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
504
Price
$313.66
Total Value
$158.09K
Shares Held After
4,453
% of Holdings
10.2%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
1,004
Price
$312.83
Total Value
$314.08K
Shares Held After
4,957
% of Holdings
16.8%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
2,854
Price
$311.91
Total Value
$890.20K
Shares Held After
5,961
% of Holdings
32.4%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
1,750
Price
$310.89
Total Value
$544.06K
Shares Held After
8,815
% of Holdings
16.6%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
999
Price
$309.38
Total Value
$309.07K
Shares Held After
10,565
% of Holdings
8.6%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
1,240
Price
$308.24
Total Value
$382.22K
Shares Held After
11,564
% of Holdings
9.7%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
683
Price
$306.77
Total Value
$209.52K
Shares Held After
12,804
% of Holdings
5.1%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
320
Price
$305.31
Total Value
$97.70K
Shares Held After
13,487
% of Holdings
2.3%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
120
Price
$303.13
Total Value
$36.38K
Shares Held After
13,807
% of Holdings
0.9%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
10
Price
$301.44
Total Value
$3.01K
Shares Held After
13,927
% of Holdings
0.1%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
4,922
Price
$85.03
Total Value
$418.52K
Shares Held After
60,137
% of Holdings
7.6%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
401
Price
$85.01
Total Value
$34.09K
Shares Held After
60,137
% of Holdings
0.7%
Revolution Medicines, Inc. (RVMD)
Anders Jack — Chief Financial Officer
Shares
300
Price
$170.32
Total Value
$51.10K
Shares Held After
123,269
% of Holdings
0.2%
Revolution Medicines, Inc. (RVMD)
Anders Jack — Chief Financial Officer
Shares
5,651
Price
$169.24
Total Value
$956.40K
Shares Held After
123,569
% of Holdings
4.4%
Revolution Medicines, Inc. (RVMD)
Anders Jack — Chief Financial Officer
Shares
9,496
Price
$168.20
Total Value
$1.60M
Shares Held After
129,220
% of Holdings
6.8%
Revolution Medicines, Inc. (RVMD)
Anders Jack — Chief Financial Officer
Shares
4,553
Price
$167.34
Total Value
$761.92K
Shares Held After
138,716
% of Holdings
3.2%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
19,973
Price
$21.02
Total Value
$419.83K
Shares Held After
1,086,063
% of Holdings
1.8%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
25,397
Price
$21.02
Total Value
$533.84K
Shares Held After
1,484,760
% of Holdings
1.7%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
50,530
Price
$21.02
Total Value
$1.06M
Shares Held After
4,755,109
% of Holdings
1.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,029
Price
$101.14
Total Value
$205.21K
Shares Held After
597,047
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
14,490
Price
$101.14
Total Value
$1.47M
Shares Held After
3,343,343
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
14,513
Price
$100.42
Total Value
$1.46M
Shares Held After
599,076
% of Holdings
2.4%
Showing 101–150 of 336 transactions (page 3 of 7)